Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1977 2
1980 2
1981 1
1983 1
1984 1
1985 1
1987 1
1989 1
1990 5
1991 5
1992 7
1993 4
1994 3
1995 4
1996 6
1997 5
1998 10
2000 5
2001 5
2002 10
2003 5
2004 3
2005 8
2006 5
2007 12
2008 3
2009 3
2010 2
2011 6
2012 11
2013 10
2014 9
2015 9
2016 8
2017 6
2018 10
2019 10
2020 12
2021 7
2022 3
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.
Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Engelmann C, et al. J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S49-S66. doi: 10.1016/j.jhep.2021.01.002. J Hepatol. 2021. PMID: 34039492 Free PMC article. Review.
Patients with acutely decompensated cirrhosis have a dismal prognosis and frequently progress to acute-on-chronic liver failure, which is characterised by hepatic and extrahepatic organ failure(s). The pathomechanisms involved in decompensation and disease progression are …
Patients with acutely decompensated cirrhosis have a dismal prognosis and frequently progress to acute-on-chronic liver failure, which is ch …
Non-cirrhotic portal hypertension - diagnosis and management.
Khanna R, Sarin SK. Khanna R, et al. J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23. J Hepatol. 2014. PMID: 23978714 Free article. Review.
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are indicated in patients with failure of endotherapy, bleeding from sites not amenable to endotherapy, symptomatic hypersplenism or symptomatic …
In EHPVO, there are additional concerns of growth faltering, portal biliopathy, MHE and parenchymal dysfunction. Surgical shunts are …
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Dyson JK, et al. Lancet. 2018 Jun 23;391(10139):2547-2559. doi: 10.1016/S0140-6736(18)30300-3. Epub 2018 Feb 13. Lancet. 2018. PMID: 29452711 Review.
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing, or both, with bile duct fibrosis. Inflammation and fibrosis of bile ducts and the liver are followed by impaired bile formation or flow an …
Primary sclerosing cholangitis is a rare, chronic cholestatic liver disease characterised by intrahepatic or extrahepatic stricturing …
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.
Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.. Sarin SK, et al. Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Hepatol Int. 2019. PMID: 31172417 Free PMC article.
The AARC database was also approached for answering some of the issues where published data were limited, such as liver failure grading, its impact on the 'Golden Therapeutic Window', extrahepatic organ dysfunction and failure, development of sepsis, distinctive features o …
The AARC database was also approached for answering some of the issues where published data were limited, such as liver failure grading, its …
Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century.
Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ. Bezerra JA, et al. Hepatology. 2018 Sep;68(3):1163-1173. doi: 10.1002/hep.29905. Hepatology. 2018. PMID: 29604222 Free PMC article. Review.
Biliary atresia (BA) is a fibroinflammatory disease of the intrahepatic and extrahepatic biliary tree. Surgical hepatic portoenterostomy (HPE) may restore bile drainage, but progression of the intrahepatic disease results in complications of portal hypertension …
Biliary atresia (BA) is a fibroinflammatory disease of the intrahepatic and extrahepatic biliary tree. Surgical hepatic portoenterost …
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Rajesh S, et al. World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561. World J Gastroenterol. 2020. PMID: 33088154 Free PMC article. Review.
More than five decades after it was originally conceptualized as rescue therapy for patients with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) procedure continues to remain a focus of intense clinical and biomedical research. By the impr …
More than five decades after it was originally conceptualized as rescue therapy for patients with intractable variceal bleeding, the transju …
Acute-on-chronic liver failure: Terminology, mechanisms and management.
Br VK, Sarin SK. Br VK, et al. Clin Mol Hepatol. 2023 Jul;29(3):670-689. doi: 10.3350/cmh.2022.0103. Epub 2023 Mar 20. Clin Mol Hepatol. 2023. PMID: 36938601 Free PMC article. Review.
Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as jaundice and coagulopathy with the development of ascites, with a high probability of extrahepatic organ involvement and high 28-day mortality. The pathogenesis involves extensive hep …
Acute-on-chronic liver failure is an acute deterioration of liver function manifesting as jaundice and coagulopathy with the development of …
Portal biliopathy.
Chattopadhyay S, Nundy S. Chattopadhyay S, et al. World J Gastroenterol. 2012 Nov 21;18(43):6177-82. doi: 10.3748/wjg.v18.i43.6177. World J Gastroenterol. 2012. PMID: 23180936 Free PMC article. Review.
Biliary ductal changes are a common radiological finding in patients with portal hypertension, however only a small percentage of patients (5%-30%) develop symptomatic bile duct obstruction. ...Portosystemic shunts are the treatment of choice for symptomatic port …
Biliary ductal changes are a common radiological finding in patients with portal hypertension, however only a small percentage …
Portal biliopathy.
Khuroo MS, Rather AA, Khuroo NS, Khuroo MS. Khuroo MS, et al. World J Gastroenterol. 2016 Sep 21;22(35):7973-82. doi: 10.3748/wjg.v22.i35.7973. World J Gastroenterol. 2016. PMID: 27672292 Free PMC article. Review.
Portal biliopathy refers to cholangiographic abnormalities which occur in patients with portal cavernoma. ...Next portal venous pressure is reduced by formation of surgical porto-systemic shunt or transjugular intrahepatic portosystemic shunt. ...
Portal biliopathy refers to cholangiographic abnormalities which occur in patients with portal cavernoma. ...Next portal …
Liver cirrhosis.
Pinzani M, Rosselli M, Zuckermann M. Pinzani M, et al. Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):281-90. doi: 10.1016/j.bpg.2011.02.009. Best Pract Res Clin Gastroenterol. 2011. PMID: 21497745 Review.
Portal hypertension results from an increased intrahepatic resistance combined with increased portal (and hepatic arterial) blood flow. The fibrotic and angio-architectural modifications of liver tissue leading to increased intrahepatic resistance and the deg …
Portal hypertension results from an increased intrahepatic resistance combined with increased portal (and hepatic arter …
210 results